Premenopausal Plasma Osteoprotegerin and Breast Cancer Risk: A Case-Control Analysis Nested within the Nurses' Health Study II.

Joanne KotsopoulosEmma E McGee Susana Lozano-Esparza Judy E GarberJennifer LigibelLaura C CollinsKornelia PolyakMyles BrownSteven NarodRulla M TamimiA Heather Eliassen

Published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2020)

Results do not provide strong evidence for OPG as a potential biomarker of breast cancer risk among premenopausal women.

Keyphrases

breast cancer risk
case control
healthcare
mental health
public health
health information
nuclear factor
type diabetes
skeletal muscle
social media